Back to Journals » Clinical Ophthalmology » Volume 15

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca

Total article views   HTML views PDF downloads Totals
2,850 Dovepress* 2,656+ 597 3,253
PubMed Central* 194 63 257
Totals 2,850 660 3,510
*Since 12 January 2021

View citations on PubMed Central and Google Scholar